Invention Grant
![Pyrazolo[3,4-D]pyrimidin derivative and its use for the treatment of leishmaniasis](/docs/US/2019-04-09/US10253028B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[3,4-D]pyrimidin derivative and its use for the treatment of leishmaniasis
-
Application No.: US15545193Application Date: 2016-01-21
-
Publication No.: US10253028B2Publication Date: 2019-04-09
- Inventor: Timothy James Miles , Michael George Thomas
- Applicant: GlaxoSmithKline Intellectual Property Development Limited , University of Dundee
- Applicant Address: GB Brentford, Middlesex GB Dundee
- Assignee: GlaxoSmithKline Intellectual Property Development Limited,University of Dundee
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited,University of Dundee
- Current Assignee Address: GB Brentford, Middlesex GB Dundee
- Agent Nicole Ginanni; Duke M. Fitch
- Priority: EP15382011 20150123
- International Application: PCT/EP2016/051240 WO 20160121
- International Announcement: WO2016/116563 WO 20160728
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D487/04
![Pyrazolo[3,4-D]pyrimidin derivative and its use for the treatment of leishmaniasis](/abs-image/US/2019/04/09/US10253028B2/abs.jpg.150x150.jpg)
Abstract:
The compound 3,3,3-trifluoro-N-((1,4-trans)-4-((3-((S)-2-methylmorpholino)-IH-pyrazolo[3,4-d]pyrimidin-6-yl)amino)cyclohexyl)propane-1-sulfonamide having the Formula (I) or a salt thereof, its opposite enantiomer, compositions comprising the compound and its use in the treatment or prevention of leishmaniasis, particularly visceral leishmaniasis.
Public/Granted literature
- US20170369496A1 PYRAZOLO[3,4-D]PYRIMIDIN DERIVATIVE AND ITS USE FOR THE TREATMENT OF LEISHMANIASIS Public/Granted day:2017-12-28
Information query
IPC分类:
